Z-0896-2022 Class II Terminated
FDA device recall Z-0896-2022 was initiated by DRG International, Inc. on Dec 21, 2021 and is designated Class II. Reason for recall: ODs of the standards too low(< 0.6 ODmax) may cause invalid runs, delayed patient results are possible The recall status is terminated (terminated Feb 12, 2024). Affected quantity: 3 Kits.
Recall details
- Product Type
- Devices
- Report Date
- Apr 13, 2022
- Initiation Date
- Dec 21, 2021
- Termination Date
- Feb 12, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3 Kits
Product description
C-Peptide ELISA : IVD measurement of C-Peptide in serum, plasma (EDTA-, heparin- or citrate plasma) and urine. Catalog # EIA-1293
Reason for recall
ODs of the standards too low(< 0.6 ODmax) may cause invalid runs, delayed patient results are possible
Distribution pattern
NY
Code information
Lot# / Expiration dates: 20K061 / 2022-06-30 20K071 / 2022-07-31 20K081 / 2022-08-31
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0896-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026